Prosight Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-8,685
| Closed | -$1.33M | – | 52 |
|
2021
Q1 | $1.33M | Sell |
8,685
-167,053
| -95% | -$25.5M | 1.09% | 27 |
|
2020
Q4 | $27.5M | Buy |
175,738
+59,938
| +52% | +$9.36M | 12.69% | 1 |
|
2020
Q3 | $13.3M | Buy |
115,800
+25,800
| +29% | +$2.95M | 6.3% | 1 |
|
2020
Q2 | $10.1M | Sell |
90,000
-50,000
| -36% | -$5.61M | 4.34% | 5 |
|
2020
Q1 | $12.6M | Buy |
+140,000
| New | +$12.6M | 5.88% | 4 |
|